Cochlear Implantation in Patients with Neurofibromatosis Type 2 and Patients with Vestibular Schwannoma in the Only Hearing Ear
Author(s) -
Erika CelisAguilar,
Luis Lassaletta,
Javiér Gavilán
Publication year - 2012
Publication title -
international journal of otolaryngology
Language(s) - English
Resource type - Journals
eISSN - 1687-921X
pISSN - 1687-9201
DOI - 10.1155/2012/157497
Subject(s) - medicine , neurofibromatosis type 2 , schwannoma , neurofibromatosis , vestibular system , audiology , cochlear nerve , cochlear implantation , promontory , cochlear implant , hearing loss , cochlea , surgery , radiology , history , archaeology
Cochlear implants are a new surgical option in the hearing rehabilitation of patients with neurofibromatosis type 2 (NF2) and patients with vestibular schwannoma (VS) in the only hearing ear. Auditory brainstem implant (ABI) has been the standard surgical treatment for these patients. We performed a literature review of patients with NF2 and patients with VS in the only hearing ear. Cochlear implantation (CI) provided some auditory benefit in all patients. Preservation of cochlear nerve integrity is crucial after VS resection. Results ranged from environmental sound awareness to excellent benefit with telephone use. Promontory stimulation is recommended although not crucial. MRI can be performed safely in cochlear implanted patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom